Galectin Therapeutics Statistics
Total Valuation
GALT has a market cap or net worth of $209.23 million. The enterprise value is $255.32 million.
Market Cap | 209.23M |
Enterprise Value | 255.32M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
Earnings Date | May 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
GALT has 61.90 million shares outstanding. The number of shares has increased by 1.29% in one year.
Shares Outstanding | 61.90M |
Shares Change (YoY) | +1.29% |
Shares Change (QoQ) | +3.62% |
Owned by Insiders (%) | 31.12% |
Owned by Institutions (%) | 11.69% |
Float | 42.69M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.77
Current Ratio | 1.77 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -15.00 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -197.70% |
Return on Capital (ROIC) | -389.40% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.60M |
Employee Count | 28 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +83.70% in the last 52 weeks. The beta is 0.88, so GALT's price volatility has been lower than the market average.
Beta (1Y) | 0.88 |
52-Week Price Change | +83.70% |
50-Day Moving Average | 2.49 |
200-Day Moving Average | 1.97 |
Relative Strength Index (RSI) | 57.26 |
Average Volume (30 Days) | 146,708 |
Short Selling Information
The latest short interest is 2.25 million, so 3.63% of the outstanding shares have been sold short.
Short Interest | 2.25M |
Short Previous Month | 2.14M |
Short % of Shares Out | 3.63% |
Short % of Float | 5.26% |
Short Ratio (days to cover) | 21.23 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -38.07M |
Pretax Income | -44.69M |
Net Income | -44.81M |
EBITDA | -41.86M |
EBIT | -41.89M |
Earnings Per Share (EPS) | -$0.74 |
Balance Sheet
The company has $25.66 million in cash and $71.74 million in debt, giving a net cash position of -$46.08 million or -$0.74 per share.
Cash & Cash Equivalents | 25.66M |
Total Debt | 71.74M |
Net Cash | -46.08M |
Net Cash Per Share | -$0.74 |
Equity / Book Value | -61.96M |
Book Value Per Share | -1.00 |
Working Capital | 12.03M |
Cash Flow
Operating Cash Flow | -32.97M |
Capital Expenditures | n/a |
Free Cash Flow | -32.97M |
FCF Per Share | -$0.55 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GALT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.29% |
Shareholder Yield | -1.29% |
Earnings Yield | -21.41% |
FCF Yield | -15.76% |
Analyst Forecast
The average price target for GALT is $11.00, which is 225.44% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $11.00 |
Price Target Difference | 225.44% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 23, 2012. It was a reverse split with a ratio of 1:6.
Last Split Date | Mar 23, 2012 |
Split Type | Reverse |
Split Ratio | 1:6 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |